Shotaro Nakanishi, Tetsuji Suda, Kei Tanaka, Tomoko Yonamine, Kenji Numahata, Ai Sugawa, Takuma Oshiro, Yoshinori Oshiro, Seiichi Saito, Junichi Inokuchi. MUC1 expression is associated with ST3GAL2 and negatively correlated with the androgen receptor in castration-resistant prostate cancer. Glycoconjugate Journal. 2024
Shotaro Nakanishi, Masato Goya, Tetsuji Suda, Tomoko Yonamine, Ai Sugawa, Seiichi Saito. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma. BMC urology. 2024. 24. 1. 94-94
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, Tomoaki Hakariya, Hiroaki Kakinoki, Hideki Enokida, Katsuaki Chikui, Hirofumi Matsuoka, Toshitaka Shin, Shoichiro Mukai, et al. Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan. International journal of urology : official journal of the Japanese Urological Association. 2024. 31. 5. 484-491
Naotaka Nishiyama, Yuki Kita, Katsuhiro Ito, Minoru Kato, Shingo Hatakeyama, Yuto Matsushita, Sei Naito, Makito Miyake, Shotaro Nakanishi, Yoichiro Kato, et al. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site. Anticancer research. 2023. 43. 11. 5041-5050
Rikiya Taoka, Takashi Kobayashi, Yu Hidaka, Hiroyasu Abe, Katsuhiro Ito, Takahiro Kojima, Minoru Kato, Souhei Kanda, Shingo Hatakeyama, Yoshiyuki Matsui, et al. Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma. Urologic oncology. 2022. 40. 3. 107.e1-107.e9
